Showing results (441-450 of 1,545) with videos related to
Sort By:
Pageof 155
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras)M J Rapoport, L Weiss, A Mor, et al.Journal of Community Health|August 1, 1994
Health care reform as perceived by first year medical studentsM S Wilkes, S A Skootsky, C S Hodgson, et al.Clinical and Experimental Immunology|June 1, 1997
Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functionsB L Shirkey, S Slavin, B P Vistica, et al.Bone Marrow Transplantation|April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamideM Bitan, R Or, M Y Shapira, et al.Bone Marrow Transplantation|July 25, 2006
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?E Hirshfeld, L Weiss, J Kasir, et al.Academic Medicine : Journal of the Association of American Medical Colleges|April 1, 1994
Entering first-year medical students' attitudes toward managed careM S Wilkes, S A Skootsky, S Slavin, et al.Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.Diabetologia|December 1, 1994
Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drugD J Gross, H Sidi, L Weiss, et al.Leukemia Research|October 7, 2008
Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphomaM Har-Noy, M Zeira, L Weiss, et al.Bone Marrow Transplantation|February 1, 1996
Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodiesG Chaushu, S Chaushu, S Slavin, et al.Pageof 155